Evelo Biosciences, Inc.
Evelo Biosciences, Inc.（EVLO）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
evlo · 股价预测 · 8 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 8 位华尔街分析师
Buy
8 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.00
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.00 | ↑ 0.00% |
1-day model range: $0–$0. Peak: $0 (+0.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · EVLO · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-10-18 | TD Cowen | Downgrade ↓ | Outperform→Market Perform |
| 2023-07-26 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2023-02-15 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2022-11-16 | Chardan Capital | Downgrade ↓ | Buy→Neutral |
| 2022-09-09 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2022-08-24 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2022-08-15 | Chardan Capital | Maintains | Buy→Buy |
| 2021-11-02 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2021-11-01 | Chardan Capital | Upgrade ↑ | Neutral→Buy |
| 2021-06-23 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Evelo Biosciences, Inc. (EVLO) stock. Of the recent 27 rating actions, 2 were upgrades and 4 were downgrades. 8 analysts currently cover EVLO.
分析师推荐趋势
EVLO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
Revenue Next Year
$0M
EPS This Year
$-2.26
EPS Next Year
$-2.57
↑ 13.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast EVLO EPS of $-2.26 for the current fiscal year, based on estimates from 1 analysts. The EVLO revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
EVLO 股价预测由两类独立数据源支撑：来自 8 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。EVLO 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
EVLO 的短期预测（明日）为 $0.00（+0.00%）。
Evelo Biosciences, Inc. 在 OTC 上市，代码 EVLO。EVLO 在 2027 年的整体展望偏积极，在覆盖分析师中约 63% 对应 Buy 共识。
常见问题
EVLO 预测 · 8 个问题根据 8 位华尔街分析师，EVLO 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $0.00，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.